Origin Agritech Ltd. (NASDAQ: SEED) (the 'Company' or 'Origin'), a leading Chinese agricultural technology company, today announced it has entered into a patent license agreement with Shandong ...

Market opportunities lie in modernizing software development and validation approaches, emphasizing agility and continuous validation to meet changing needs, while ensuring compliance with FDA ...

Eli Lilly is inking a $100 million-plus biobucks deal with Insilico Medicine in hopes of using AI to discover new drugs. | Eli Lilly is inking a $100 million-plus biobucks deal with Insilico Medicine ...

Evaxion Biotech’s overall score is driven by strong technical indicators and positive developments from the earnings call, including R&D progress and financial stability. However, financial ...

The eClinical Solutions Market is booming due to rising R&D investments and demand for faster drug development. Key ...

High-performance computing, artificial intelligence, and quantum computing are transforming scientific research, enabling breakthroughs in drug discovery, climate modeling, and materials science. But ...

Eli Lilly will partner with Insilico Medicine on an artificial intelligence (AI)-based drug development collaboration that they said could generate “over $100 million” for the AI drug discovery ...

Bahrain’s sovereign wealth fund Mumtalakat has partnered with US-based technology company SandboxAQ with the collaboration ...

The U.S. inked Technology Prosperity Deals (TPD) with Japan and South Korea with an eye toward spurring collaboration on AI, ...

MARTi enables real-time nanopore metagenomics, helping researchers detect and respond to microbial threats across diverse environments.

After years on the sidelines while investors piled into the next big thing in AI or crypto, biotech is back in focus. The question is whether this rally marks a real recovery or just another ...